The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tokumaru, S.
Right arrow Articles by Hashimoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokumaru, S.
Right arrow Articles by Hashimoto, K.
The Journal of Immunology, 2005, 175: 4662-4668.
Copyright © 2005 by The American Association of Immunologists

Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-371

Sho Tokumaru2,*, Koji Sayama2,3,*, Yuji Shirakata*, Hitoshi Komatsuzawa{dagger}, Kazuhisa Ouhara{dagger}, Yasushi Hanakawa*, Yoko Yahata*, Xiuju Dai*, Mikiko Tohyama*, Hiroshi Nagai*, Lujun Yang*, Shigeki Higashiyama{ddagger}, Akihiko Yoshimura§, Motoyuki Sugai{dagger} and Koji Hashimoto*

* Department of Dermatology, Ehime University School of Medicine, Ehime, Japan; {dagger} Department of Bacteriology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; {ddagger} Department of Molecular and Cellular Biology, Division of Biochemistry and Molecular Genetics, Ehime University School of Medicine, Ehime, Japan; and § Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

The closure of skin wounds is essential for resistance against microbial pathogens, and keratinocyte migration is an important step in skin wound healing. Cathelicidin hCAP18/LL-37 is an innate antimicrobial peptide that is expressed in the skin and acts to eliminate microbial pathogens. Because hCAP18/LL-37 is up-regulated at skin wound sites, we hypothesized that LL-37 induces keratinocyte migration. In this study, we found that 1 µg/ml LL-37 induced the maximum level of keratinocyte migration in the Boyden chamber assay. In addition, LL-37 phosphorylated the epidermal growth factor receptor (EGFR) after 10 min, which suggests that LL-37-induced keratinocyte migration occurs via EGFR transactivation. To test this assumption, we used inhibitors that block the sequential steps of EGFR transactivation, such as OSU8-1, CRM197, anti-EGFR no. 225 Ab, and AG1478. All of these inhibitors completely blocked LL-37-induced keratinocyte migration, which indicates that migration occurs via HB-EGF-mediated EGFR transactivation. Furthermore, CRM197, anti-EGFR no. 225, and AG1478 blocked the LL-37-induced phosphorylation of STAT3, and transfection with a dominant-negative mutant of STAT3 abolished LL-37-induced keratinocyte migration, indicating the involvement of the STAT3 pathway downstream of EGFR transactivation. Finally, we tested whether the suppressor of cytokine signaling (SOCS)/cytokine-inducible Src homology 2-containing protein (CIS) family of negative regulators of STAT3 regulates LL-37-induced keratinocyte migration. Transfection with SOCS1/Jak2 binding protein or SOCS3/CIS3 almost completely abolished LL-37-induced keratinocyte migration. In conclusion, LL-37 induces keratinocyte migration via heparin-binding-EGF-mediated transactivation of EGFR, and SOCS1/Jak 2 binding and SOCS3/CIS3 negatively regulate this migration. The results of this study suggest that LL-37 closes skin wounds by the induction of keratinocyte migration.


Related articles in The JI:

IN THIS ISSUE

The JI 2005 175: 4159-4160. [Full Text]  



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
T. Shimura, H. Kataoka, N. Ogasawara, E. Kubota, M. Sasaki, S. Tanida, and T. Joh
Suppression of proHB-EGF Carboxy-Terminal Fragment Nuclear Translocation: A New Molecular Target Therapy for Gastric Cancer
Clin. Cancer Res., June 15, 2008; 14(12): 3956 - 3965.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Dierssen, N. Beraza, H. H. Lutz, C. Liedtke, M. Ernst, H. E. Wasmuth, and C. Trautwein
Molecular Dissection of gp130-dependent Pathways in Hepatocytes during Liver Regeneration
J. Biol. Chem., April 11, 2008; 283(15): 9886 - 9895.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Menard, V. Forster, M. Lotz, D. Gutle, C. U. Duerr, R. L. Gallo, B. Henriques-Normark, K. Putsep, M. Andersson, E. O. Glocker, et al.
Developmental switch of intestinal antimicrobial peptide expression
J. Exp. Med., January 21, 2008; 205(1): 183 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Yu, N. Mookherjee, K. Wee, D. M. E. Bowdish, J. Pistolic, Y. Li, L. Rehaume, and R. E. W. Hancock
Host Defense Peptide LL-37, in Synergy with Inflammatory Mediator IL-1beta, Augments Immune Responses by Multiple Pathways
J. Immunol., December 1, 2007; 179(11): 7684 - 7691.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K.-P. Xu, J. Yin, and F.-S. X. Yu
SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2832 - 2839.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. C. Huang, T. D. Petkova, R. Y. Reins, R. J. Proske, and A. M. McDermott
Multifunctional Roles of Human Cathelicidin (LL-37) at the Ocular Surface.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2369 - 2380.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Pochet, S. Tandel, S. Querriere, M. Tre-Hardy, M. Garcia-Marcos, M. De Lorenzi, M. Vandenbranden, A. Marino, M. Devleeschouwer, and J.-P. Dehaye
Modulation by LL-37 of the Responses of Salivary Glands to Purinergic Agonists
Mol. Pharmacol., June 1, 2006; 69(6): 2037 - 2046.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.